Revolution Medicines Inc

42Z

Company Profile

  • Business description

    Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

  • Contact

    700 Saginaw Drive
    Redwood CityCA94063
    USA

    T: +1 650 481-6801

    https://www.revmed.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    883

Stocks News & Analysis

stocks

Big IPOs are enticing but are they good investments?

Historically, buzzy debuts have been painful for buyers.
stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.
stocks

Chart of the Week: Anthropic’s IPO range sits below our fair value

Our fair value is above the IPO range, but outcomes could differ widely.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,720.50116.10-1.31%
CAC 408,080.7466.09-0.81%
DAX 4025,463.81272.43-1.06%
Dow JONES (US)49,097.061,101.11-2.19%
FTSE 10010,452.6898.49-0.93%
HKSE22,841.62453.13-1.95%
NASDAQ23,879.20550.69-2.25%
Nikkei 22558,215.981,228.23-2.07%
NZX 50 Index14,129.92117.33-0.82%
S&P 5007,175.83147.80-2.02%
S&P/ASX 2008,617.30113.10-1.30%
SSE Composite Index3,577.6210.21-0.28%

Market Movers